Pipeline led by a new proprietary oral small molecule GLP-1 agonist and six additional innovative programs targeting the GIP, Amylin…
HOUSTON and SINGAPORE, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Respiree, a health tech company developing artificial intelligence (AI) platforms to…
CHANDLER, Ariz., Aug. 05, 2025 (GLOBE NEWSWIRE) -- To better support server OEMs, storage systems, data centers and enterprise customers,…
August 05, 2025 07:04 ET | Source: Virtune AB (Publ) Stockholm, 5 August 2025 - Virtune today announces the completion…
TORONTO, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Xtract One Technologies (TSX: XTRA)(OTCQX: XTRAF)(FRA: 0PL) (“Xtract One” or the “Company”) today…
Recent lab results proved the Company’s hypothesis that disguising cancer cells to look like common infectious diseases can trick immune…
Has more than 30 years of experience bringing innovations to market, including one of the world’s first drug-eluting coronary stents…
First patient in Phase I/II clinical trial expected to be enrolled in Q4 2025UK Clinical Trial Application (CTA) approval shortly…
August 04, 2025 08:05 ET | Source: MaxCyte, Inc MaxCyte’s Flow Electroporation® technology and ExPERT™ platform to support development of…
TAMPA, Fla., Aug. 04, 2025 (GLOBE NEWSWIRE) -- Full Alliance Group, Inc. (OTC: FAGI) today announced the formation of QUBEE…